NEOLIPIDRA FORTE Composition:
Each NEOLIPIDRA FORTE tablet contains 240 milligrams of highly concentrated 1% (1%) extract of the metabolites of the yeast Monascus purpureus.
The other ingredients of the tablet are calcium hydrogen phosphate, corn starch, povidone, copovidone, magnesium stearate.
Description:
NEOLIPIDRA FORTE is a biotechnological product obtained during the fermentation of the yeast Monascus purpureus on wet rice.
The biologically active substances in the composition of NEOLIPIDRA FORTE are: 14 different monacolins - HMG-CoA reductase inhibitors, sterols, isoflavones, mono- and polyunsaturated fatty acids, saturated fatty acids, pigments.
How NEOLIPIDRA FORTE works
The main biologically active substances in NEOLIPIDRA FORTE are monacolins. They suppress the formation of cholesterol in the liver. The lowering of cholesterol is partly due to the action of other biologically active substances.
What we need to know about cholesterol
Cholesterol is a type of fat in the blood. Cholesterol in the blood comes from two sources. Most of the cholesterol is produced in the liver. The other source of cholesterol is food. Total cholesterol in the body consists of LDL and HDL cholesterol.
LDL cholesterol is called "bad" cholesterol because it can build up on the walls of blood vessels and form atherosclerotic plaques. Over time, plaques grow and narrow blood vessels, especially arteries. This narrowing makes it difficult or impossible to completely block the blood supply. to vital organs such as the heart, brain, etc. High LDL cholesterol is the leading cause of cardiovascular disease, heart attack and stroke.
HDL cholesterol is called "good" cholesterol because it prevents "bad"
Who should not take NEOLIPIDRA FORTE
It is not recommended to use NEOLIPIDRA FORTE in cases of:
• Hypersensitivity to any of the components of the tablet, as well as some hypersensitivity to yeast. The most common symptoms of an allergic reaction include rash, itching, swelling of the lips and face, shortness of breath. Talk to your doctor if you experience any of these symptoms.
• Pregnancy, planning a pregnancy or breastfeeding.
Application:
NEOLIPIDRA FORTE is suitable for use in patients with elevated cholesterol levels without other comorbidities, as well as in patients with ischemic heart disease to reduce the risk of myocardial infarction, unstable angina pectoris and coronary vascular revascularization procedures.
NEOLIPIDRA FORTE simultaneously reduces the levels of total cholesterol, LDL - "bad" cholesterol and triglycerides
NEOLIPIDRA FORTE raises HDL levels - "good" cholesterol
NEOLIPIDRA FORTE does not interact with other drugs
NEOLIPIDRA FORTE is applicable to all patients who cannot take other cholesterol-lowering drugs.
NEOLIPIDRA FORTE allows long-term long-term use without damaging the liver
Taking NEOLIPIDRA FORTE does not cause side effects with more than 4 years of use.
Side Effects:
No side effects from the use of the drug were observed in therapeutic doses. In case of overdose, transient gastrointestinal symptoms such as burning behind the sternum (reflux), dry mouth, bloating, gas and vomiting may occur. When the dose is normalized, these symptoms disappear quickly. NEOLIPIDRA FORTE is generally well tolerated, side effects are usually mild and transient.
Dosage:
The dose of NEOLIPIDRA FORTE is determined by body weight and severity. NEOLIPIDRA FORTE is
usually taken 1 tablet of 240 mg twice a day. or 480 mg. daily. The evaluation of the effectiveness of NEOLIPIDRA FORTE should be performed no earlier than 8 weeks after the start of administration.
In case of unsatisfactory reduction of the levels of total cholesterol and LDL-cholesterol and in patients with high body weight, it is recommended to increase the daily dose by another 1 tablet. The additional dose of 1 tablet is given with the evening intake, ie. 1 tablet in the morning and 2 tablets in the evening or a total daily intake of 3 tablets (720 mg.).
If you need to further increase the daily dose to 4 tablets (960 mg / day), take 2 tablets in the morning and 2 tablets in the evening. The daily dose should not exceed 4 tablets or 960 mg.